← Back to Clinical Trials
RecruitingNCT07202195

At Home Use of Stimulation Suits for Managing MS Symptoms

◆ AI Clinical Summary

This study tests whether wearing a full-body stimulation suit at home can help people with Multiple Sclerosis reduce symptoms like muscle stiffness and poor coordination. Participants will use the suit at home and be monitored to see if it improves their daily functioning and quality of life.

Key Objective:The trial is testing whether at-home use of a stimulation suit can reduce MS symptoms like spasticity and ataxia while improving daily functioning.

Who to Consider:People with Multiple Sclerosis who experience spasticity or coordination problems and are interested in trying a non-medication approach to manage their symptoms should consider enrolling.

Trial Parameters

ConditionMultiple Sclerosis
SponsorDaphne Kos
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment70
SexALL
Min Age18 Years
Max AgeN/A
Start Date2026-03
Completion2027-09
Interventions
electro-stimulation suitUsual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study is being carried out at Multiple Sclerosis (MS) centers to evaluate whether a full-body stimulation suit at home can help people with Multiple Sclerosis (pwMS) reduce symptoms like spasticity (muscle stiffness) and ataxia (poor coordination), and improve daily functioning. Can pwMS who experience spasticity or ataxia benefit from using a stimulation suit for 6 weeks? Researchers will compare two groups: an intervention group (who will use the suit) and a control group (who will not use the suit). Participants in the intervention group will: * Wear the suit for 6 weeks in total every day or every other day (1 week during their MS center admission and 5 weeks at home). * Receive their usual care in addition to wearing the suit. * Undergo clinical tests at the MS center after 1 week and 6 weeks of stimulation. Participants in the control group will: * Receive their usual care. * Undergo clincial tests at the same time points as the other group.

Eligibility Criteria

Inclusion Criteria: * Eligible participants must have ataxia or spasticity alongside impairments in upper or lower extremity physical function. MAS score ≥ 1 will be used as an inclusion criterion to determine the presence of spasticity. SARA score ≥ 4 will be used as an inclusion criterion to determine the presence of ataxia. Note: one of the two criteria (MAS score or SARA score) must be fulfilled for a pwMS to be eligible. * The patient must have the cognitive abilities to understand instructions and to be able to complete the questionnaires adequately * Diagnosis of multiple sclerosis. Exclusion Criteria: * Implanted devices (like pacemaker, Baclofen pump, neurostimulator, defibrillator, shunts, ECG equipment, electronic life support, high frequency operation equipment ) * Change in disease modifying treatment within the last 3 months * Use of Botuline Toxine A within the last 3months * Recent relapse within the last 3 months * Acute musculoskeletal problems that hinder the test pe

Related Trials